CompanyLBRXNasdaqNew York, NY

LB Pharmaceuticals Inc.

LB Pharmaceuticals develops neuromedicines for brain disorders.

SEC EDGAR ClinicalTrials.gov lbpharma.us

424B4Sep 28Latest SEC filing

Sep 15Latest story

September 2026

LB Pharmaceuticals names Susan Kozauer as chief medical officer

Sep 15PeopleLB Pharmaceuticals Inc.

LB Pharmaceuticals names Joseph Miller as chief financial officer

Sep 3PeopleLB Pharmaceuticals Inc.LB-102

August 2026

LB Pharmaceuticals moves up NOVA-2 schizophrenia readout to first half of 2027

Aug 11Quarterly updateLB Pharmaceuticals Inc.LB-102

July 2026

LB Pharmaceuticals sets $150 million private placement of stock and warrants

Jul 29FinancingLB Pharmaceuticals Inc.LB-102

LB Pharmaceuticals moves up NOVA-2 schizophrenia trial readout to first half of 2027

Jul 22Clinical readoutLB Pharmaceuticals Inc.LB-102